Use of rivaroxaban attenuates renal function impairment in patients with atrial fibrillation: insights of the EMIR study

Background In atrial fibrillation (AF) patients on vitamin K antagonists, a progressive deterioration of renal function is common but there is limited evidence with long‐term use of rivaroxaban. Herein, we investigated the change in renal function in AF patients after 2 years of rivaroxaban treatmen...

Ausführliche Beschreibung

Bibliographische Detailangaben

Veröffentlicht in:	European journal of clinical investigation 2022-09, Vol.52 (9), p.e13788-n/a
Hauptverfasser:	López‐Gálvez, Raquel, Rivera‐Caravaca, José Miguel, Anguita Sánchez, Manuel, Sanmartín Fernández, Marcelo, Rafols, Carles, Pérez‐Cabeza, Alejandro Isidoro, Barón Esquivias, Gonzalo, Lekuona Goya, Iñaki, Vázquez Rodríguez, José Manuel, Cosín Sales, Juan, Arribas Ynsaurriaga, Fernando, Barrios, Vivencio, Freixa‐Pamias, Román, Marín, Francisco
Format:	Artikel
Sprache:	eng
Schlagworte:	Antagonists atrial fibrillation Cardiac arrhythmia Creatinine DOACs Fibrillation Impairment Patients renal dysfunction Renal function rivaroxaban Vitamin K
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!